Literature DB >> 8465766

Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism.

C J Weinheimer1, M A Brown, R Nohara, J E Perez, S R Bergmann.   

Abstract

To test the hypothesis that recovery of myocardial oxidative metabolism (MVO2) is a necessary prerequisite for recovery of contractile function following reperfusion and to evaluate its dependency on the interval of antecedent ischemia before reflow, we evaluated 11 dogs serially for 4 weeks. Six dogs were subjected to prompt reperfusion (after 1 hour of coronary artery occlusion) and five were subjected to delayed reperfusion (after 4 hours of ischemia). Despite equivalent levels of myocardial blood flow with reperfusion, hearts subjected to prompt reperfusion had faster and more complete recovery of MVO2 (assessed by sequential positron emission tomography with [11C]acetate) and function (assessed by echocardiography) compared with dogs subjected to delayed reperfusion. Infarct size was diminished in dogs with prompt reperfusion. In all dogs, recovery of function with reperfusion was predicted and correlated with early recovery of MVO2 (r = 0.61, p < 0.04). The results demonstrate that prompt reperfusion is associated with more rapid and complete recovery of oxidative metabolism and function and support the hypothesis that the ability to metabolize substrate oxidatively is a necessary prerequisite for recovery of function.

Entities:  

Mesh:

Year:  1993        PMID: 8465766     DOI: 10.1016/0002-8703(93)90100-n

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Use of carbon 11-acetate for the measurement of myocardial oxygen consumption.

Authors:  O Akinboboye; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  Postrevascularization recovery of fatty acid utilization in ischemic myocardium: a randomized clinical trial of potassium channel opener.

Authors:  Y Kuwabara; S Watanabe; J Nakaya; R Hasegawa; K Matsuno; T Kuroda; Y Mikami; K Fujii; A Miyazaki; T Saito; Y Masuda
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

Review 3.  Current status of viability assessment with positron tomography.

Authors:  N Tamaki
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

4.  Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: comparison with rest-redistribution thallium 201 imaging.

Authors:  A S Iskandrian; J Powers; V Cave; V Wasserleben; D Cassell; J Heo
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

Review 5.  The use of carbon 11-labeled acetate for assessment of aerobic metabolism.

Authors:  J A Melin; J L Vanoverschelde; A Bol; G Heyndrickx; W Wijns
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

Review 6.  Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.

Authors:  R Valkema; B L van Eck-Smit; E E van der Wall
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

Review 7.  Assessment of left ventricular dysfunction by nuclear cardiology.

Authors:  J A Melin; W Wijns; J L Vanoverschelde; G R Heyndrickx
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 8.  Imaging of Myocardial Oxidative Metabolism in Heart Failure.

Authors:  Masanao Naya; Nagara Tamaki
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.